Sarepta Therapeutics Inc (SRPT) - Financial and Strategic SWOT Analysis Review

Sarepta Therapeutics Inc (SRPT) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Sarepta Therapeutics Inc (Sarepta) discovers and develops unique RNA-targeted medicines to treat rare diseases. The company develops its pipeline products using its multi-platform Precision Genetic Medicine Engine in gene therapy, RNA, and gene editing. The company’s platform is based on its pioneering work with phosphorodiamidate morpholino oligomer (PMO) chemistries. Its commercial products include Exondys 51, Vyondys 53, Elevidys and Amondys 45 indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene. Its pipeline product includes SRP-5051, SRP-9003 and SRP-9004 indicated for the treatment of DMD, limb-girdle muscular dystrophies (LGDMs) and other neuromuscular and central nervous system disorders. Sarepta is headquartered in Cambridge, Massachusetts, the US.

Sarepta Therapeutics Inc Key Recent Developments

May 01,2024: Sarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate Developments
Feb 28,2024: Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Developments
Jan 08,2024: Sarepta Therapeutics Reports Preliminary* Fourth Quarter and Full-Year 2023 Net Product Revenue
Nov 01,2023: Sarepta Therapeutics Announces Third Quarter 2023 Financial Results and Recent Corporate Developments

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Sarepta Therapeutics Inc - Key Facts
Sarepta Therapeutics Inc - Key Employees
Sarepta Therapeutics Inc - Key Employee Biographies
Sarepta Therapeutics Inc - Major Products and Services
Sarepta Therapeutics Inc - History
Sarepta Therapeutics Inc - Company Statement
Sarepta Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Sarepta Therapeutics Inc - Business Description
Other Break-up: Collaboration and Other
Performance
Other Break-up: Products
Performance
R&D Overview
Sarepta Therapeutics Inc - Corporate Strategy
Sarepta Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Sarepta Therapeutics Inc - Strengths
Sarepta Therapeutics Inc - Weaknesses
Sarepta Therapeutics Inc - Opportunities
Sarepta Therapeutics Inc - Threats
Sarepta Therapeutics Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Sarepta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Sarepta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Sarepta Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 01, 2024: Sarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate Developments
Feb 28, 2024: Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Developments
Jan 08, 2024: Sarepta Therapeutics Reports Preliminary Fourth Quarter and Full-Year 2023 Net Product Revenue
Nov 01, 2023: Sarepta Therapeutics Announces Third Quarter 2023 Financial Results and Recent Corporate Developments
Aug 31, 2023: Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 02, 2023: Sarepta Therapeutics Announces Second Quarter 2023 Financial Results and Recent Corporate Developments
Jul 26, 2023: Sarepta Therapeutics to Announce Second Quarter 2023 Financial Results
May 02, 2023: Sarepta Therapeutics Announces First Quarter 2023 Financial Results and Recent Corporate Developments
Apr 05, 2023: Third International Limb Girdle Muscular Dystrophy Conference to be held in Washington, D.C. On October 27-29, 2023
Feb 28, 2023: Sarepta Therapeutics announces call for applications for the 6th Annual Route 79, The Duchenne Scholarship Program
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Sarepta Therapeutics Inc, Key Facts
Sarepta Therapeutics Inc, Key Employees
Sarepta Therapeutics Inc, Key Employee Biographies
Sarepta Therapeutics Inc, Major Products and Services
Sarepta Therapeutics Inc, History
Sarepta Therapeutics Inc, Subsidiaries
Sarepta Therapeutics Inc, Key Competitors
Sarepta Therapeutics Inc, Ratios based on current share price
Sarepta Therapeutics Inc, Annual Ratios
Sarepta Therapeutics Inc, Annual Ratios (Cont...1)
Sarepta Therapeutics Inc, Annual Ratios (Cont...2)
Sarepta Therapeutics Inc, Interim Ratios
Sarepta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Sarepta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Sarepta Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Sarepta Therapeutics Inc, Performance Chart (2019 - 2023)
Sarepta Therapeutics Inc, Ratio Charts
Sarepta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Sarepta Therapeutics Inc, Pharmaceuticals & He

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings